Market data loadingS&P 500--NASDAQ--Data as of latest ETNo timestamp

ROCKWELL MEDICAL, INC. (RMTI) Market Cap & Valuation Ratios

ROCKWELL MEDICAL, INC. (RMTI) has a market cap of $28.0M and a price-to-sales ratio of 0.4, with earnings according to EquiReason's reading of its SEC filings.

Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason

RMTIROCKWELL MEDICAL, INC.Follow RMTI — free
Drug Manufacturers - General · Healthcare
—
Price chart with a free account
Market cap
28.0M
P/E TTM
—
Dividend yield
—
52-week
—
Next earnings
12 Nov, in 19 days

Peers

drug manufacturers - general · nearest by market cap · trailing 12 months
CompanyMkt cap, $BP/EEV/SalesEV/EBITDAFCF yieldRev. growthOp. marginROIC
RMTI0.0—0.4—5.5%-21%-7%-15%
AMRN0.3———6.0%-15%-22%-13%
ABEO0.3—4.7———-328%-157%
LYEL0.2—963.0——-55%—-142%
EVMN0.2————+86%—-47%
FHTX0.1—1.4——+52%-198%—
YARW0.1—59.2——+1%——
IBO0.0—878.5—-1.7%——-47%
GTBP0.0———————
CMMB0.01.1——————
LGVN0.0————-43%——
Median of these 101.159.2—2.2%-7%-198%-47%

; EV/Sales 0.4 vs. 59.2.

Growth vs. price

each dot a company · hover or tap for values

ROCKWELL MEDICAL, INC. — questions

What is ROCKWELL MEDICAL, INC.'s market cap?
$28.0M.
What is ROCKWELL MEDICAL, INC.'s price-to-sales ratio?
0.4.

Every figure on this page comes from ROCKWELL MEDICAL, INC.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.

How these figures are read: methodology · EquiReason.